Who is sponsoring NCT05705713?

NCT05705713 is sponsored by Menoufia University.

What drugs are being tested in NCT05705713?

Interventions in NCT05705713: chest computed tomography (CT).

What condition does NCT05705713 study?

NCT05705713 studies Inhalation Injury.

Is NCT05705713 still recruiting?

NCT05705713 is currently completed. Last updated 1 February 2023.

Last reviewed 2023-02-01 · How we verify

NCT05705713

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

First-day Computed Tomography: Does it Has a Role in the Assessment of Patients With Inhalation Lung Injury?

Completed NA Last updated 1 February 2023

What this trial tests

NA trial testing chest computed tomography (CT) in Inhalation Injury in 58 participants. Completed in 1 March 2019.

Timeline

1 December 2015

Primary endpoint
1 January 2019

1 March 2019

Quick facts

Lead sponsor	Menoufia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	58
Start date	1 December 2015
Primary completion	1 January 2019
Estimated completion	1 March 2019

Drugs / interventions tested

chest computed tomography (CT)

Conditions studied

Inhalation Injury — all drugs for Inhalation Injury →

Sponsor

Menoufia University

Who can join

18 and older, any sex, with Inhalation Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A major risk factor for death in burn victims is inhalation lung injury. Diagnostic criteria and severity grading are not well understood. After an inhalation injury, the mucociliary escalator is impaired by induced mucosal hyperemia, which includes Edema, increased mucous production, and airway exudation, and these insults worsen airway narrowing which interferes with ventilation. Multimodal therapy and quick bronchoscopic diagnosis improve patient outcomes. Early identification and classification of inhalation injuries improve patient outcomes. Chest CT may be employed as an alternative to or supplement to the bronchoscopy as well as a diagnostic and prognostic tool. In this study, the diagnostic and prognostic value of bronchial wall thickening as a radiological CT finding in inhalation lung damage and the radiologist score (RADS) were evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Menoufia University trials

Trials by the same sponsor.

NCT07522671 — Clinical Performance of 3D-Printed Resin and Zirconia Implant Restorations · NA · recruiting
NCT07516236 — Dynamic SvO2 in Predicting Fluid Responsiveness in Septic Shock · not yet recruiting
NCT07485517 — Deep Versus Moderate Neuromuscular Blocking · NA · recruiting
NCT07506044 — Dexmedetomidine as an Adjuvant During Dural Puncture Epidural · NA · recruiting
NCT07322471 — Efficacy and Safety of Flexible Ureteroscopy Versus Percutaneous Nephrolithotomy in Management of Staghorn Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05705713 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Menoufia University
Last refreshed: 1 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05705713.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing